Xiujun Wu
About Xiujun Wu
Xiujun Wu serves as the Associate Director at Brii Biosciences in the San Francisco Bay Area, a position he has held since 2021. He has a strong background in analytical chemistry and has previously worked at Gilead Sciences and Nektar Therapeutics.
Work at Brii Biosciences
Xiujun Wu has served as Associate Director at Brii Biosciences since 2021. In this role, Wu contributes to the company's mission in the biopharmaceutical sector, focusing on innovative treatments and solutions. The position is based in the San Francisco Bay Area, a hub for biotechnology and life sciences.
Previous Experience at Gilead Sciences
Prior to joining Brii Biosciences, Xiujun Wu worked at Gilead Sciences as a Senior Associate Scientist from 2013 to 2021. During this eight-year tenure, Wu was involved in significant projects within the organization, contributing to the development of therapies in the biopharmaceutical field. This experience provided a strong foundation in scientific research and development.
Educational Background
Xiujun Wu holds a Master's degree in Analytical Chemistry from the University of Alabama in Huntsville. Additionally, Wu earned a Bachelor's degree from Donghua University. This educational background equips Wu with a solid understanding of chemistry and its applications in research and development.
Research and Teaching Experience
Before entering the industry, Xiujun Wu worked as a Graduate Research and Teaching Assistant at the University of Alabama in Huntsville from 2002 to 2004. This role involved supporting academic research initiatives and assisting in teaching responsibilities, contributing to both educational and research advancements.
Career at Nektar Therapeutics
Xiujun Wu was employed at Nektar Therapeutics as a Senior Research Associate in Analytical Development from 2005 to 2013. During this eight-year period, Wu focused on analytical methods and development processes, enhancing skills in research and contributing to the company's projects in drug development.